The ERA-NET “European Innovative Research & Technological Development Project in Nanomedicine” (EuroNanoMed) has published the 3rd call to generate transnational collaboration for research and development in the field of Nanomedicine in Europe EURONANOMED 2011

About: The main purpose of the call is to generate transnational collaboration for research and development in the field of Nanomedicine

Project proposals will address multidisciplinary and translational research in one of the following fields:

a) Regenerative medicine

b) Diagnostics

c) Targeted delivery systems

Proposals may include, but are not limited to: identification, characterisation and validation of biomarkers, early diagnosis, convergence of nanotechnology and stem cell technology, standardization of stem cells for regenerative therapy, cell biology applied to nanomedicine, multimodal imaging agents or techniques, point of care diagnostics (on site sensors), standardized procedures for preparation & characterization of drug delivery systems, gene or cell therapies using nanotechnology and development and use of nanomaterials for medical purposes. Clinical studies are eligible up to the point of proof of concept.

Project proposals must clearly demonstrate the potential health impact and/or business plan and economic impact as well as the added-value of transnational collaboration: sharing of resources (models, registries, diagnosis, etc.), harmonization of data, sharing of specific know-how and/or innovative technologies.

Eligibility: Each proposal must involve a minimum of 3 and a maximum of 7 partners including at least two EuroNanoMed states participating in the 3rd joint transnational call: (Spain, Basque region (Spain), France, Germany, Iceland, Israel, Latvia, Lithuania, Poland, Romania, , Switzerland, , Turkey, Veneto Region (Italy), Walloon Region (Belgium). It is mandatory to have a consortium comprising group(s) from at least two out of the three following categories: academia, clinical/public health research sector; enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) is encouraged.

Support: Spanish participation is funded by Institut de Salud Carlos III with a total budget of € 0.5 M€ for Spanish participants.

Spanish participation: University hospitals, other hospitals and other health care settings will be considered eligible as beneficiary of the 2nd International Joint Call.

Timeline

Deadline for submitting proposals: 15th April 2011.ç

Further information; Euronanomed Submission